Definition: Initially referred to as ‘dementia praecox’, schizophrenia affects thoughts, emotions, and behaviours.
SIMPLE: Gradual withdrawal from reality.
PARANOID: Presence of delusions and hallucinations.
CATATONIC: Involves disturbances in motor activity.
Symptoms must persist for at least one month and cannot be attributed to other health conditions.
Symptoms categorised as either:
Positive Symptoms: e.g. persistent delusions, hallucinations, thought disorder, experiences of influence.
Negative Symptoms: e.g. avolition, flattened affect, impaired cognitive function, catatonia.
Aim: To investigate early-onset schizophrenia through case studies.
Procedure: A case study of a boy who showed significant behavioural changes post-divorce, leading to schizophrenia diagnosed at age 12.
Findings: The boy experienced auditory hallucinations and aggressive behaviour despite medication.
Conclusion: Highlighted the complexities of early-onset schizophrenia.
Evaluation: Emphasises the use of case studies but limits generalisability.
Context: Explores the use of virtual reality (VR) to investigate persecutory ideation in healthy individuals.
Aim:
To see if individuals without a mental illness experience persecutory thoughts in a VR setting.
To identify cognitive or emotional predictors of such ideation.
Procedure:
24 participants (12 male, 12 female) from University College London without mental illness history.
Participants used VR to explore a library scene with avatars showing ambiguous behaviour.
Measured paranoia levels before and after VR using a series of questionnaires, including the Brief Symptom Inventory (BSI) and VR-Paranoia questionnaire.
Findings: Significant correlation between scores on the paranoia questionnaire and interview. Increased interpersonal sensitivity and anxiety correlated with persecutory thoughts.
Conclusion: Individuals attribute mental states to VR characters, allowing for the investigation of persecutory ideation.
Evaluation: Highlights VR as a standardised approach to assess behaviours and brings insights on interpersonal sensitivity influencing thoughts.
Schizophrenia tends to develop in adolescence or early adulthood.
Affects men and women equally, but men suffer more severely.
1/3 of diagnosed individuals improve with treatment, 1/3 worsen, 1/3 have long-term institutionalisation.
Before the dopamine hypothesis, treatment options were limited, often resulting in hospitalisation.
Antipsychotics emerged in the 1950s, targeting dopamine activity.
Antipsychotics reduce symptoms by blocking dopamine receptors (especially D2 receptors).
Typical antipsychotics: Phenothiazines like Haloperidol and Chlorpromazine.
Typical (1st Generation): Block D2 receptors, effective on positive symptoms (delusions, hallucinations).
Side effects: Tardive Dyskinesia, extrapyramidal symptoms (EPS), sedation, weight gain.
Atypical (2nd Generation): Bind less to D2, more to D1 and D4 receptors.
Examples: Risperidone, Olanzapine, Clozapine.
Side effects: Weight gain, drowsiness.
Provide evidence for the effectiveness of antipsychotics, comparing treatment and control groups.
Aim: Assess effectiveness of antipsychotics in children/adolescents with schizophrenia.
Procedure: Meta-analysis of 15 studies comparing first- and second-generation.
Findings: Both generations superior to placebo; clozapine was most effective.
Conclusion: Extrapyramidal side effects more common in 1st generation drugs.
Includes Lurasidone and Aripiprazole with fewer side effects.
Definition: Induction of seizures via electrical stimulation; used for severe cases.
Procedure: 6-12 sessions, monitors for memory loss, rarely causes lasting damage.
Aim: Review ECT’s effectiveness in schizophrenia.
Findings: Effective in treating catatonic schizophrenia and improving medication response.
Conclusion: More effective in conjunction with medication, especially for catatonia.
Definition: Cognitive treatment with behavioural elements focused on modifying thoughts and beliefs.
Models: Thoughts influence feelings and behaviours; improving coping skills is key.
Aim: Test CBT effectiveness against a control group (befriending).
Procedure: 90 patients with distressing symptoms over 6 months; random assignment to treatments.
Findings: Both groups showed significant improvement, but CBT group maintained improvements at follow-up.
Conclusion: CBT positively impacts both positive and negative symptoms.
Strengths: Effective for positive symptoms, reduce relapse rates.
Weaknesses: Side effects, limited efficacy for negative symptoms, non-adherence issues.
Strengths: Rapid symptom relief for treatment-resistant cases, effective for severe agitation.
Weaknesses: Temporary effects, potential ethical concerns.
Strengths: Non-chemical; addresses cognitive distortions and coping mechanisms.
Weaknesses: Limited efficacy during acute episodes; access and cost issues.
Idiographic vs Nomothetic Approaches: Research generally aims for broad generalisations of effective treatments through robust data sets.